ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,369Medicare Part D Prescriptions Filled, Including Refills

Rank: 170 out of 1107

$705K Total Retail Price of All Prescriptions

Rank: 220 out of 1107

383 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 383 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 383 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 9,043 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 720 353 S3 1 1
LEVOTHYROXINE SODIUM 541 408 2 3
SIMVASTATIN 491 304 3 5
LISINOPRIL 484 285 4 2
FUROSEMIDE 435 314 5 7
METFORMIN HCL 434 258 6 8
OMEPRAZOLE 376 214 7 4
ATENOLOL 240 182 8 19
PRAVASTATIN SODIUM 236 143 9 12
WARFARIN SODIUM 219 149 10 15
HYDROCHLOROTHIAZIDE 213 177 11 11
CRESTOR 207 149 12 23
NEXIUM 190 116 13 18
CITALOPRAM HBR 189 107 14 17
GABAPENTIN 184 107 15 9
METOPROLOL TARTRATE 180 156 16 10
AMLODIPINE BESYLATE 176 140 17 6
ATORVASTATIN CALCIUM 164 93 18 13
POTASSIUM CHLORIDE 157 111 19 14
CLOPIDOGREL 157 111 19 28
LOSARTAN POTASSIUM 148 123 21 29
RANITIDINE HCL 135 76 22 21
VYTORIN 135 82 22 169
GLIPIZIDE 125 70 24 64
CARVEDILOL 123 82 25 27
ISOSORBIDE MONONITRATE ER 120 92 26 34
AMOX TR-POTASSIUM CLAVULANATE 120 67 26 131
ZETIA 118 88 28 76
PLAVIX 116 91 29 39
TAMSULOSIN HCL 115 91 30 30
POLYETHYLENE GLYCOL 3350 114 106 31 46
FLUTICASONE PROPIONATE 106 45 32 38
METOPROLOL SUCCINATE 105 69 33 16
TRAZODONE HCL 98 52 34 33
LEVOFLOXACIN 98 66 34 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 59 36 24
SINGULAIR 94 38 36 65
PROMETHAZINE HCL 88 38 R 38 44
MELOXICAM 86 60 39 25
TRICOR 84 39 40 95
DILTIAZEM 24HR CD 83 60 41 126
ZOLPIDEM TARTRATE 79 30 42 22
ACTOS 79 52 42 132
LEVOCETIRIZINE DIHYDROCHLORIDE 77 16 44 203
AMITRIPTYLINE HCL 76 38 R 45 48
CLONIDINE HCL 76 62 45 53
NIASPAN 76 53 45 125
TRAMADOL HCL 75 33 48 26
DIOVAN 74 65 49 51
DONEPEZIL HCL 74 62 49 32
VENTOLIN HFA 73 25 51 97
ENDOCET 71 36 S2 52 91
AMLODIPINE BESYLATE-BENAZEPRIL 66 50 53 77
BENAZEPRIL HCL 66 52 53 86
METFORMIN HCL ER 65 54 55 58
FENOFIBRATE 64 18 56 67
SPIRIVA 64 35 56 57
NAPROXEN 63 43 58 80
ADVAIR DISKUS 63 27 58 54
SERTRALINE HCL 63 26 58 20
ALLOPURINOL 62 46 61 36
KLOR-CON M10 62 55 61 159
CYCLOBENZAPRINE HCL 62 39 R 61 56
MONTELUKAST SODIUM 61 23 64 118
LOVAZA 60 24 65 101
PAROXETINE HCL 60 33 65 45
NOVOLOG MIX 70-30 FLEXPEN 60 33 65 371
PROPRANOLOL HCL 58 19 68 134
FENTANYL 57 41 S2 69 105
FAMOTIDINE 56 43 70 111
GLIPIZIDE ER 55 39 71 115
SYNTHROID 55 36 71 70
KLOR-CON M20 54 40 73 75
DICLOFENAC SODIUM 54 37 73 74
PROAIR HFA 54 19 73 37
CYMBALTA 54 0 73 50
GLIMEPIRIDE 54 16 73 43
HYDROXYZINE HCL 52 27 R 78 162
PROVENTIL HFA 51 49 79 394
LANSOPRAZOLE 51 47 79 102
NOVOLIN 70-30 50 50 81 209
ALENDRONATE SODIUM 50 36 81 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.